Aadi Bioscience

    OverviewSuggest Edit

    Aadi Bioscience is a biopharmaceutical company developing an albumin-bound mTOR inhibitor for targeted patient populations in oncology, cardiovascular, and CNS diseases. It offers ABI-009, a nanoparticle albumin-bound sirolimus (rapamycin), an active form of sirolimus complexed with albumin.

    Latest Updates

    Employees (est.) (Mar 2020)3

    Key People/Management at Aadi Bioscience

    Neil Desai

    Neil Desai

    Founder, CEO and President, Chairman
    Richard Maroun

    Richard Maroun

    Board Member
    Jerry Xiao

    Jerry Xiao

    Board Member
    Mahendra Shah

    Mahendra Shah

    Board Member
    Show more

    Aadi Bioscience Financials and Metrics

    Summary Metrics

    Founding Date

    Show all financial metrics

    Aadi Bioscience Online and Social Media Presence

    Embed Graph

    Aadi Bioscience Frequently Asked Questions

    • When was Aadi Bioscience founded?

      Aadi Bioscience was founded in 2011.

    • Who are Aadi Bioscience key executives?

      Aadi Bioscience's key executives are Neil Desai, Richard Maroun and Jerry Xiao.

    • How many employees does Aadi Bioscience have?

      Aadi Bioscience has 3 employees.

    • Who are Aadi Bioscience competitors?

      Competitors of Aadi Bioscience include Northwest Biotherapeutics, Merrimack Pharmaceuticals and CytomX Therapeutics.